Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 15;11(24):7454.
doi: 10.3390/jcm11247454.

Answering Clinical Questions Using Machine Learning: Should We Look at Diastolic Blood Pressure When Tailoring Blood Pressure Control?

Affiliations

Answering Clinical Questions Using Machine Learning: Should We Look at Diastolic Blood Pressure When Tailoring Blood Pressure Control?

Maciej Siński et al. J Clin Med. .

Abstract

Background: The guidelines recommend intensive blood pressure control. Randomized trials have focused on the relevance of the systolic blood pressure (SBP) lowering, leaving the safety of the diastolic blood pressure (DBP) reduction unresolved. There are data available which show that low DBP should not stop clinicians from achieving SBP targets; however, registries and analyses of randomized trials present conflicting results. The purpose of the study was to apply machine learning (ML) algorithms to determine, whether DBP is an important risk factor to predict stroke, heart failure (HF), myocardial infarction (MI), and primary outcome in the SPRINT trial database. Methods: ML experiments were performed using decision tree, random forest, k-nearest neighbor, naive Bayesian, multi-layer perceptron, and logistic regression algorithms, including and excluding DBP as the risk factor in an unselected and selected (DBP < 70 mmHg) study population. Results: Including DBP as the risk factor did not change the performance of the machine learning models evaluated using accuracy, AUC, mean, and weighted F-measure, and was not required to make proper predictions of stroke, MI, HF, and primary outcome. Conclusions: Analyses of the SPRINT trial data using ML algorithms imply that DBP should not be treated as an independent risk factor when intensifying blood pressure control.

Keywords: SPRINT trial; cardiovascular risk; diastolic blood pressure; machine learning.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flowchart presenting ML experiment phases. DBP—diastolic blood pressure, SMOTE—synthetic minority oversampling technique.
Figure 2
Figure 2
Comparison of the performance of the classifiers when DBP was included (DBP (+)) and excluded (DBP (−)) as the predictor presented as boxplots for all outcome variables examined in the unselected population. AUC—area under curve, mF1—mean F-measure, wF1—mean weighted F-measure, no differences detected for all of the comparisons.
Figure 3
Figure 3
Comparison of the performance of the classifiers when DBP was included (DBP (+)) and excluded (DBP (−)) as the predictor presented as boxplots for all outcome variables examined in the selected population of subjects with DBP < 70 mmHg. AUC—area under curve, mF1—mean F-measure, wF1—mean weighted F-measure, no differences detected for all of the comparisons.
Figure 4
Figure 4
Comparison of the performance of the classifiers in the selected (selection) and unselected (no selection) population presented as boxplots for all of outcome variables when diastolic blood pressure was included and excluded as the predictor. AUC—area under curve, mF1—mean F-measure, wF1—mean weighted F-measure, no differences detected for all of the comparisons.
Figure 5
Figure 5
ROC curves of the classifiers detecting of primary outcome when DBP was included as the risk factor. DT—decision tree formula image, KNN—k-nearest neighbor classifier formula image, LR—logistic regression formula image, MLP—multi-layer perceptron formula image, NB—naive Bayesian classifier formula image, RF—random forest formula image.

Similar articles

References

    1. Williams B., Mancia G., Spiering W., Agabiti Rosei E., Azizi M., Burnier M., Clement D.L., Coca A., de Simone G., Dominiczak A., et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur. Heart J. 2018;39:3021–3104. doi: 10.1093/eurheartj/ehy339. - DOI - PubMed
    1. Sobieraj P., Lewandowski J., Sinski M. Determination of the optimal on-treatment diastolic blood pressure range using automated office measurements in patients without cardiovascular disease. Pol. Arch. Int. Med. 2021;131:249–256. doi: 10.20452/pamw.15789. - DOI - PubMed
    1. Stewart I.M. Relation of reduction in pressure to first myocardial infarction in patients receiving treatment for severe hypertension. Lancet. 1979;1:861–865. doi: 10.1016/S0140-6736(79)91274-1. - DOI - PubMed
    1. Alderman M.H., Ooi W.L., Madhavan S., Cohen H. Treatment-induced blood pressure reduction and the risk of myocardial infarction. JAMA. 1989;262:920–924. doi: 10.1001/jama.1989.03430070068032. - DOI - PubMed
    1. Sobieraj P., Lewandowski J., Sinski M., Symonides B., Gaciong Z. Low Diastolic Blood Pressure is Not Related to Risk of First Episode of Stroke in a High-Risk Population: A Secondary Analysis of SPRINT. J. Am. Heart Assoc. 2019;8:e010811. doi: 10.1161/JAHA.118.010811. - DOI - PMC - PubMed